SPOTLIGHT: Church & Dwight to buy Del Labs' drugs

Coty is selling off the pharma business of Del Laboratories, which makes Orajel, for $380 million to Church & Dwight of Arm & Hammer fame. The deal comes three years after Church & Dwight walked away from an agreement to buy Del Labs with a private-equity firm. Release

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.